Genetic test-kit company 23andMe Inc. has for years used saliva to tell millions of consumers how closely related they are to Neanderthals or whether they are likely to develop diseases like diabetes or Alzheimer’s. Now, it’s fulfilling a bigger ambition: drug development.
For the past year, 23andMe has been sharing its huge trove of genetic data with drug giant GlaxoSmithKline PLC, which took a $300 million stake last summer. That collaboration has so far produced six potential drug targets, and the companies expect to start...
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
I started noticing all the soldiers with the back of there heads cut open they can't figure out why they can't get them chips out without surgery.